4.8 Review

Nanoparticles Mediated the Diagnosis and Therapy of Glioblastoma: Bypass or Cross the Blood-Brain Barrier

Related references

Note: Only part of the references are listed.
Article Chemistry, Multidisciplinary

PTN-PTPRZ1 signaling axis blocking mediates tumor microenvironment remodeling for enhanced glioblastoma treatment

Meng Yang et al.

Summary: A self-assembled dual-targeted hybrid micelle (DT-GM1) was developed as a nanocarrier to deliver the chemotherapeutic agent doxorubicin (DOX). The DT-GM1/DOX was shown to cross the blood-brain barrier and target the tumor microenvironment enriched with immunosuppressed M2-like tumor-associated macrophages (M2 TAMs) and glioblastoma stem cells (GSCs), resulting in increased intracellular drug accumulation and reshaping of the immune microenvironment. This nanocarrier provides a promising new strategy for glioblastoma (GBM) treatment.

JOURNAL OF CONTROLLED RELEASE (2023)

Article Engineering, Biomedical

Deep brain stimulation by blood-brain-barrier-crossing piezoelectric nanoparticles generating current and nitric oxide under focused ultrasound

Taejeong Kim et al.

Summary: Deep brain stimulation through implanted electrodes is effective for neuronal disorders, but limited by side effects. This study demonstrates that systemically administered piezoelectric nanoparticles, activated by high-intensity focused ultrasound, can stimulate deep brain tissue without direct brain electrode insertion. The nanoparticles temporarily disrupt the blood-brain barrier and stimulate dopamine release, effectively alleviating symptoms in a Parkinson's disease mouse model. This strategy has potential for developing minimally invasive therapies for neurodegenerative diseases.

NATURE BIOMEDICAL ENGINEERING (2023)

Article Chemistry, Multidisciplinary

Radiation-Triggered Selenium-Engineered Mesoporous Silica Nanocapsules for RNAi Therapy in Radiotherapy-Resistant Glioblastoma

Xianglong Tang et al.

Summary: In this study, a biodegradable selenium-engineered mesoporous silica nano-capsule was developed for at-site RNA interference to inhibit the invasive growth of radiotherapy-resistant glioblastoma (rrGBM) and achieve maximum therapeutic benefit. The nanocapsule showed high stability, efficient blood-brain barrier penetration, and potent accumulation in rrGBM. It effectively reduced tumor growth and invasion, prolonging survival in an rrGBM model.

ACS NANO (2023)

Review Chemistry, Inorganic & Nuclear

Recent advances on modulation of H2O2 in tumor microenvironment for enhanced cancer therapeutic efficacy

Zhaoyou Chu et al.

Summary: Due to the higher concentration of hydrogen peroxide (H2O2) in tumor cells compared to normal cells, it can be used as an effective target for tumor therapy to differentiate between normal tissues and produce differential therapeutic effects. This review focuses on modulating H2O2-related strategies through direct delivery of exogenous factors and amplifying endogenous genes, which show promising results in cancer treatment. The review also discusses the obstacles that need to be overcome and the bright future in H2O2 modulation.

COORDINATION CHEMISTRY REVIEWS (2023)

Article Chemistry, Multidisciplinary

Modulation of blood-brain tumor barrier for delivery of magnetic hyperthermia to brain cancer

Haoan Wu et al.

Summary: This study proposes a novel approach for the treatment of glioblastoma, using targeted delivery of fingolimod to the brain tumor region to modulate the blood-brain tumor barrier (BBTB) and deliver magnetic hyperthermia.

JOURNAL OF CONTROLLED RELEASE (2023)

Review Nanoscience & Nanotechnology

Polymer nanocarriers for targeted local delivery of agents in treating brain tumors

Alexander D. Josowitz et al.

Summary: Glioblastoma presents significant challenges to the development of new therapies. Standard treatments have not seen much improvement in the past 17 years, and there is a lack of new chemotherapies. However, new technologies and techniques are being explored to overcome the obstacles in delivering drugs to the brain. Local delivery and the use of nanocarriers offer promising opportunities to improve the safety and efficacy of treatment.

NANOTECHNOLOGY (2023)

Article Chemistry, Multidisciplinary

Homotypic Membrane-Enhanced Blood-Brain Barrier Crossing and Glioblastoma Targeting for Precise Surgical Resection and Photothermal Therapy

Hang Zhang et al.

Summary: In this study, gold nanorods were cloaked with GBM patient-derived tumor cell membrane (GBM-PDTCM) to achieve efficient blood-brain barrier (BBB) crossing and selective glioblastoma (GBM) targeting. Fluorescence and Raman signals generated by GBM-PDTCM@AuNRs were used to guide precise tumor resection, improving surgical treatment for advanced GBM. Additionally, intravenous injection of GBM-PDTCM@AuNRs enabled photothermal therapy for early GBM, doubling the median survival time of orthotopic xenograft mice.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2023)

Article Engineering, Biomedical

Graphene Oxide Nanoscale Platform Enhances the Anti-Cancer Properties of Bortezomib in Glioblastoma Models

Paul S. Sharp et al.

Summary: Graphene-based 2D nanomaterials have unique physicochemical characteristics that can be used in various biomedical applications, such as drug delivery and treatment. This study investigates the distribution of thin graphene oxide (GO) nanosheets in GBM mouse models and designs a novel nano-chemotherapeutic approach using GO sheets as platforms for drug complexation. The results demonstrate enhanced cytotoxic effects of the GO-BTZ complex in vivo.

ADVANCED HEALTHCARE MATERIALS (2023)

Article Chemistry, Multidisciplinary

NIR-II Perylene Monoimide-Based Photothermal Agent with Strengthened Donor-Acceptor Conjugation for Deep Orthotopic Glioblastoma Phototheranostics

Jun Guan et al.

Summary: This study reports the first example of a small organic molecule (N1) derived from perylene monoamide (PMI) that absorbs in the second near-infrared (NIR-II) bio-window and its application as a nano-agent for phototheranostics of deep orthotopic glioblastoma (GBM). The obtained N1 can absorb in the 1000-1400 nm region and exhibit high photothermal conversion. Nano-encapsulation of N1 using an amphiphilic copolymer incorporating a choline analogue enables efficient blood-brain barrier (BBB) crossing and demonstrates excellent photoacoustic imaging and significant growth inhibition of deep orthotopic GBM.

SMALL (2023)

Article Chemistry, Multidisciplinary

Biomimetic Nanosonosensitizers Combined with Noninvasive Ultrasound Actuation to Reverse Drug Resistance and Sonodynamic-Enhanced Chemotherapy against Orthotopic Glioblastoma

Huaqing Chen et al.

Summary: In this study, biomimetic nanosonosensitizer systems (MDNPs) combined with noninvasive ultrasound (US) were introduced for the targeted delivery and enhanced chemotherapy of glioblastoma (GBM). The MDNPs, made of biodegradable and pH-sensitive polyglutamic acid (PGA) and the chemotherapeutic agent and sonosensitizer doxorubicin (DOX), camouflaged with human GBM U87 cell membranes, showed homologous targeting accumulation and in vivo long-term circulation ability. With the assistance of US, the MDNPs effectively crossed the blood-brain barrier (BBB) and reached the orthotopic GBM site. The MDNPs exhibited controllable US-elicited sonodynamic effect by generating reactive oxygen species (ROS), inducing cancer cell apoptosis and disrupting chemoresistance.

ACS NANO (2023)

Article Pharmacology & Pharmacy

Synergistic effect of doxorubicin lauroyl hydrazone derivative delivered by α-tocopherol succinate micelles for the treatment of glioblastoma

Mingchao Wang et al.

Summary: The study found that tocopherol succinate (TOS) and D-a-tocopherol polyethylene2000 succinate (TPGS2000) micelles could enhance the anti-cancer efficacy for the treatment of glioblastoma.

INTERNATIONAL JOURNAL OF PHARMACEUTICS-X (2023)

Article Chemistry, Multidisciplinary

Neisseria meningitidis Opca Protein/MnO2 Hybrid Nanoparticles for Overcoming the Blood-Brain Barrier to Treat Glioblastoma

Cheng-Yuan Dong et al.

Summary: This study demonstrates a bionic nanotherapeutic system that effectively overcomes the blood-brain barrier and improves the treatment of glioblastoma by loading chemotherapy drugs into modified nanoparticles.

ADVANCED MATERIALS (2022)

Article Chemistry, Multidisciplinary

Brain-Targeted Aggregation-Induced-Emission Nanoparticles with Near-Infrared Imaging at 1550 nm Boosts Orthotopic Glioblastoma Theranostics

Jiefei Wang et al.

Summary: This study presents the development of brain-targeted near-infrared IIb aggregation-induced-emission nanoparticles via rational design, achieving a balance between fluorescence imaging and photothermal therapy demands. The nanoparticles, grafted with ApoE peptide, demonstrate efficient BBB traversal and enhanced survival in mice with orthotopic GBM, highlighting a new theranostic approach for the treatment of GBM.

ADVANCED MATERIALS (2022)

Review Biochemistry & Molecular Biology

The role of SLC transporters for brain health and disease

Yen T. K. Nguyen et al.

Summary: The brain exchanges nutrients and small molecules with blood through the blood-brain barrier, and glucose plays a critical role in providing energy for the brain. The brain also takes up various substances through different transport systems, and unraveling these mechanisms is key in understanding the brain's nutritional requirements and potential therapeutic interventions for neurological disorders.

CELLULAR AND MOLECULAR LIFE SCIENCES (2022)

Article Instruments & Instrumentation

Intranasal drug delivery: opportunities and toxicologic challenges during drug development

Lea-Adriana Keller et al.

Summary: In the last decade, there has been a growing interest in intranasal drug delivery in pharmaceutical R&D. This review article highlights the advantages of nasal delivery for local and systemic drug delivery, as well as for CNS indications, compared to conventional systemic approaches. However, formulation limitations and toxicological considerations remain areas that need further optimization in this field.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2022)

Article Chemistry, Multidisciplinary

Enhanced nose-to-brain delivery of siRNA using hyaluronan-enveloped nanomicelles for glioma therapy

YuLing Yang et al.

Summary: In this study, a multifunctional nanomicelle was developed for intranasal delivery of siRNA in glioma therapy. The nanomicelle effectively delivered siRNA to the central nervous system and inhibited tumor growth. Toxicity tests showed no adverse effects on the nasal mucosa and trigeminal nerves.

JOURNAL OF CONTROLLED RELEASE (2022)

Article Clinical Neurology

Convection-enhanced delivery for high-grade glioma

Jennifer H. Kang et al.

Summary: This review summarizes the challenges in treating glioblastoma (GBM) and the role of convection-enhanced delivery (CED) as a treatment modality. It highlights practical considerations in clinical care and the ongoing development of CED technology.

NEURO-ONCOLOGY PRACTICE (2022)

Article Chemistry, Multidisciplinary

Brain-Targeted Codelivery of Bcl-2/Bcl-xl and Mcl-1 Inhibitors by Biomimetic Nanoparticles for Orthotopic Glioblastoma Therapy

Wenya He et al.

Summary: In this study, the researchers discovered that the Mcl-1-specific inhibitor A12 synergizes with ABT to induce potent cell apoptosis in GBM. They also developed a biomimetic nanomedicine that can effectively deliver ABT and A12 to the brain, exhibiting good biocompatibility and efficient blood-brain barrier penetration. This nanomedicine effectively suppressed tumor growth and prolonged the survival time of mice with GBM xenografts without inducing adverse effects.

ACS NANO (2022)

Article Chemistry, Multidisciplinary

Nano-Codelivery of Temozolomide and siPD-L1 to Reprogram the Drug-Resistant and Immunosuppressive Microenvironment in Orthotopic Glioblastoma

Daozhou Liu et al.

Summary: In this study, a nanoparticle loaded with TMZ and siPD-L1 was prepared to reprogram the TMZ-resistant and immunosuppressive microenvironment in GBM. The nanoparticle showed potential application in treating TMZ-resistant GBM.

ACS NANO (2022)

Review Pharmacology & Pharmacy

Nanomedicine for brain cancer

Sabina Quader et al.

Summary: CNS tumors are highly lethal and treatment-resistant, mainly due to the difficulty of delivering drugs to the brain tumor site. Supramolecular nanomedicines show promise in addressing this challenge and improving brain tumor targeting.

ADVANCED DRUG DELIVERY REVIEWS (2022)

Article Biochemistry & Molecular Biology

Effects of radiofrequency exposure on in vitro blood-brain barrier permeability in the presence of magnetic nanoparticles

Fatih Senturk et al.

Summary: This study investigated the effects of radiofrequency electromagnetic fields (RF-EMFs) on the permeability of an in vitro blood-brain barrier (BBB) model. The results showed that RF exposure significantly increased the permeability of the BBB, and this effect was further enhanced in the presence of nanoparticles. The findings suggest that RF fields can be used to improve the delivery of drugs across the BBB, which is important for the treatment of neurological diseases.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)

Article Engineering, Biomedical

Targeted liposomes for combined delivery of artesunate and temozolomide to resistant glioblastoma

Muhammad Ismail et al.

Summary: A novel combination drug delivery strategy based on ApoE-functionalized liposomal nanoplatform was presented, which effectively overcame the challenges of the blood-brain barrier and drug resistance, leading to improved survival rates in mice.

BIOMATERIALS (2022)

Article Biophysics

GMT8 aptamer conjugated PEGylated Ag@Au core-shell nanoparticles as a novel radiosensitizer for targeted radiotherapy of glioma

Dongdong Li et al.

Summary: This study developed polyethylene glycol-coated Ag@Au core-shell nanoparticles (PSGNPs) modified with GMT8 aptamer (GSGNPs) and evaluated their radiosensitization effects on glioma cells through in vivo and in vitro experiments. The results demonstrated that GSGNPs showed good targeting ability, enhanced sensitization effect, and prolonged median survival time of mice bearing U87 glioma after intravenous administration combined with radiotherapy.

COLLOIDS AND SURFACES B-BIOINTERFACES (2022)

Article Materials Science, Multidisciplinary

Iron oxide nanoparticle-mediated radiation delivery for glioblastoma treatment

Peter A. Chiarelli et al.

Summary: This study introduces a tumor-targeted nanoparticle that enhances the effectiveness of radiation therapy on a selective cellular basis, improving the treatment outcomes for GBM.

MATERIALS TODAY (2022)

Article Medicine, Research & Experimental

Efficacy of Temozolomide-Conjugated Gold Nanoparticle Photothermal Therapy of Drug-Resistant Glioblastoma and Its Mechanism Study

Yawen Yu et al.

Summary: In this study, TMZ-loaded gold nanoparticles (TMZ@GNPs) with anti-EphA3 modification on the surface were synthesized for chemotherapeutic treatment. The results showed that GNPs-PPTT effectively induced apoptosis in glioma cells and reversed TMZ resistance, suggesting a promising treatment strategy for GBM.

MOLECULAR PHARMACEUTICS (2022)

Review Clinical Neurology

Advances in local therapy for glioblastoma - taking the fight to the tumour

Thomas S. van Solinge et al.

Summary: This review discusses local therapies for glioblastoma, examining treatment of the resection cavity and other direct approaches to the tumor.

NATURE REVIEWS NEUROLOGY (2022)

Article Chemistry, Multidisciplinary

Biomimetic Lipopolysaccharide-Free Bacterial Outer Membrane-Functionalized Nanoparticles for Brain-Targeted Drug Delivery

Haiyan Chen et al.

Summary: This study proposes a biomimetic nanoparticle that utilizes the BBB invasion ability of Escherichia coli K1 (EC-K1) outer membrane for brain-targeted drug delivery. The nanoparticles penetrate the BBB through the transcellular vesicle transport pathway, which is mediated by the interactions between outer membrane protein A and gp96 on BBB endothelial cells. This nanoengineering strategy provides the loaded drugs with prolonged circulation, intracranial interstitial distribution, and extremely high biocompatibility. The study also reveals the potential of delivering therapeutics to treat gp96-overexpressing intracranial malignancies.

ADVANCED SCIENCE (2022)

Article Chemistry, Multidisciplinary

Synchronous Disintegration of Ferroptosis Defense Axis via Engineered Exosome-Conjugated Magnetic Nanoparticles for Glioblastoma Therapy

Boyan Li et al.

Summary: A novel composite therapeutic platform combining magnetic nanoparticles and engineered exosomes is proposed for GBM treatment, aiming to improve the penetration through the blood-brain barrier and enhance tumor targeting ability for effective ferroptosis therapy.

ADVANCED SCIENCE (2022)

Review Oncology

Epidemiology of Glioblastoma Multiforme-Literature Review

Szymon Grochans et al.

Summary: Glioblastoma multiforme (GBM) is a highly aggressive malignancy with a median overall survival of approximately 15 months. This review analyzes the pathogenesis and epidemiological data of GBM, including age, gender, and tumor location. The data suggest that GBM is a higher-grade primary brain tumor and is significantly more common in men. Despite advancements in medicine, the risk of being diagnosed with glioma increases with age and median survival remains low. Additionally, the influence of stimulants, certain medications (such as NSAIDs), cell phone use, and exposure to heavy metals on GBM is difficult to determine clearly.

CANCERS (2022)

Article Pharmacology & Pharmacy

Development of Lomustine and n-Propyl Gallate Co-Encapsulated Liposomes for Targeting Glioblastoma Multiforme via Intranasal Administration

Gabor Katona et al.

Summary: This study aimed to develop liposomes loaded with lomustine (LOM) and n-propyl gallate (PG) for targeted treatment of glioblastoma multiforme (GBM) through the nose-to-brain drug delivery pathway. The optimized liposomal carrier showed suitable size, distribution, and encapsulation efficiency, overcoming solubility, absorption, and toxicity issues. The combination of LOM and PG in a liposomal formulation holds promise as a carrier for glioblastoma targeting via the intranasal route.

PHARMACEUTICS (2022)

Article Chemistry, Multidisciplinary

CXCR4-targeted nitric oxide nanoparticles deliver PD-L1 siRNA for immunotherapy against glioblastoma

Hsin-Tzu Hsieh et al.

Summary: The study presents an immunotherapeutic approach using CXCR4-targeted lipid-calcium-phosphate nanoparticles for the treatment of glioblastoma multiforme (GBM). By delivering nitric oxide (NO), the approach enhances blood-brain barrier permeability and improves the delivery of siRNA against the immune checkpoint ligand PD-L1 to GBM tumors. This results in increased infiltration and activation of cytotoxic T cells, suppressing GBM progression.

JOURNAL OF CONTROLLED RELEASE (2022)

Review Chemistry, Multidisciplinary

Glioma diagnosis and therapy: Current challenges and nanomaterial-based solutions

Tianzhong Li et al.

Summary: Glioma, one of the most dreadful central nervous system tumors, has a high incidence rate and remains a significant challenge for treatment. However, the development of nanomedicine provides new opportunities for long-term therapy. Various obstacles, such as the blood-brain barrier permeation, hypoxia, and complex tumor microenvironment, hinder the development of novel therapeutics. Efforts have been made to explore nanoformulations to improve permeation and address these challenges. The article provides an overview of glioma classification, pathogenic factors, current therapeutic approaches, and innovative strategies, concluding with suggestions for future improvement in diagnosis and therapy.

JOURNAL OF CONTROLLED RELEASE (2022)

Article Chemistry, Multidisciplinary

Brain-targeted antigen-generating nanoparticles improve glioblastoma prognosis

Wentao Wang et al.

Summary: This study constructed multifunctional therapeutic nanoparticles BK@MTNPs for efficient drug delivery and tumor inhibition in glioblastoma (GBM), showing a synergistic tumoricidal effect by inducing DNA damage, activating the tumor suppressor gene, inhibiting stem cell function, activating cytotoxic T lymphocytes, and reprogramming tumor-associated macrophages.

JOURNAL OF CONTROLLED RELEASE (2022)

Article Chemistry, Multidisciplinary

Photostable Small-Molecule NIR-II Fluorescent Scaffolds that Cross the Blood-Brain Barrier for Noninvasive Brain Imaging

Shichao Wang et al.

Summary: This study developed a new type of boron difluoride formazanate NIR-II dye with enhanced ability to cross the blood-brain barrier for noninvasive brain imaging. These dyes can differentiate tumors from normal brain tissues in murine models.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2022)

Article Chemistry, Multidisciplinary

Brain Co-Delivery of Temozolomide and Cisplatin for Combinatorial Glioblastoma Chemotherapy

Yan Zou et al.

Summary: A new type of GBM-cell membrane camouflaged and pH-sensitive biomimetic nanoparticles have been developed for combined TMZ and CDDP therapy for GBM. The results show that these nanoparticles can efficiently transport drugs across the blood-brain barrier and specifically target GBM, allowing for controlled release at GBM sites and demonstrating potent anti-GBM effects without obvious side effects.

ADVANCED MATERIALS (2022)

Article Engineering, Biomedical

An optimized ionizable cationic lipid for brain tumor-targeted siRNA delivery and glioblastoma immunotherapy

Shuhan Liu et al.

Summary: This study develops a novel cationic lipid nanoparticle (LNP) that efficiently delivers siRNA across the blood-brain barrier (BBB) and targets the tumor microenvironment in the brain of mice for immunotherapy of glioblastoma multiforme (GBM). The LNP is effective in delivering siRNA against CD47 and PD-L1 into the cranial GBM in mice, resulting in downregulation of target gene expression and activation of antitumor immunity.

BIOMATERIALS (2022)

Article Biotechnology & Applied Microbiology

Biomimetic calcium carbonate nanoparticles delivered IL-12 mRNA for targeted glioblastoma sono-immunotherapy by ultrasound-induced necroptosis

Pengxuan Zhao et al.

Summary: Glioblastoma is the most aggressive brain tumor with high recurrence and low survival rates. Immunotherapy has emerged as a promising treatment strategy. In this study, cRGD-modified nanoparticles were developed, which can cross the blood-brain barrier and target tumors in the brain tumor microenvironment. These biomimetic nanoparticles provide a synergistic immunotherapy approach for improved treatment outcomes.

JOURNAL OF NANOBIOTECHNOLOGY (2022)

Article Chemistry, Physical

Silicon-based nanoprobes cross the blood-brain barrier for photothermal therapy of glioblastoma

Rong Sun et al.

Summary: Researchers have developed SiNPs-based nanoprobes to bypass the blood-brain barrier for photothermal therapy of glioblastoma. These nanoprobes demonstrate improved stability and blood circulation time compared to traditional indocyanine green photothermal agents, and show superior photothermal effects in vivo.

NANO RESEARCH (2022)

Article Nanoscience & Nanotechnology

NIR-II light-assisted radiotherapy based on ultrasmall HfO2-embedded porous carbon nanooctahedra for overcoming tumor radioresistance

Y. Chen et al.

Summary: This study developed a metal-organic framework-derived nanosensitizer to improve the sensitivity of tumor radiation therapy. The nanosensitizer, composed of porous carbon nanooctahedra and high-density ultrasmall hafnium oxide, can absorb and convert X-ray energy, enhancing the effectiveness of radiation. Additionally, the nanosensitizer exhibits peroxidase-like activity and near-infrared absorption properties, enabling catalytic conversion and photothermal therapy for increased tumor cell susceptibility to radiation.

MATERIALS TODAY NANO (2022)

Article Multidisciplinary Sciences

Engineered biomimetic nanoparticles achieve targeted delivery and efficient metabolism-based synergistic therapy against glioblastoma

Guihong Lu et al.

Summary: The use of cancer cell-membrane encapsulated nanoparticles for targeted therapy in lactate-high cancer cells shows promising results in reducing tumorigenesis in glioblastoma.

NATURE COMMUNICATIONS (2022)

Article Chemistry, Multidisciplinary

Immunogenic Cell Death Augmented by Manganese Zinc Sulfide Nanoparticles for Metastatic Melanoma Immunotherapy

Zhu Li et al.

Summary: In this study, a smart micelle system was developed using an amphiphilic copolymer to encapsulate manganese zinc sulfide nanoparticles and triggered release by near infrared light. The micelles effectively enhanced reactive oxygen species generation, leading to immunogenic cell death and improved antitumor immunity in melanoma.

ACS NANO (2022)

Article Engineering, Biomedical

Biomimetic Dp44mT-nanoparticles selectively induce apoptosis in Cu-loaded glioblastoma resulting in potent growth inhibition

Muhammad Ismail et al.

Summary: The use of biomimetic nanoparticles can overcome the toxicity limitations of copper chelators in the treatment of GBM and enhance the therapeutic effect by increasing selectivity. Pre-loading tumors with copper further improves selectivity. Targeting GBM cells and modulating the apoptotic pathway can effectively suppress GBM growth.

BIOMATERIALS (2022)

Article Chemistry, Multidisciplinary

Brain-targeted CRISPR/Cas9 nanomedicine for effective glioblastoma therapy

Weimin Ruan et al.

Summary: The brain-targeted CRISPR/Cas9 based nanomedicine successfully crossed the blood-brain barrier and accumulated in brain tumors with the help of angiopep-2 peptide functionality, leading to an improved gene knockout efficiency for glioblastoma treatment and suppression of tumor growth.

JOURNAL OF CONTROLLED RELEASE (2022)

Article Biochemistry & Molecular Biology

Oncolytic Newcastle Disease Virus Co-Delivered with Modified PLGA Nanoparticles Encapsulating Temozolomide against Glioblastoma Cells: Developing an Effective Treatment Strategy

Zahraa A. Kadhim et al.

Summary: In this study, TMZ-loaded PLGA nanoparticles were prepared and co-administered with oncolytic Newcastle Disease Virus (NDV) for the treatment of GBM. The synergistic effects of the nano-formulation and viral strain combined therapy were observed on the cancer cell lines, demonstrating their potential for GBM treatment.

MOLECULES (2022)

Article Chemistry, Multidisciplinary

A biodegradable nanocapsule for through-skull NIR-II fluorescence imaging/magnetic resonance imaging and selectively enhanced radio-chemotherapy for orthotopic glioma

Na Yin et al.

Summary: By constructing theranostic nanocapsules, fluorescence-guided surgery and effective treatment of glioblastoma can be achieved, showing great potential and prospects.

NANO TODAY (2022)

Article Multidisciplinary Sciences

Bacteria loaded with glucose polymer and photosensitive ICG silicon-nanoparticles for glioblastoma photothermal immunotherapy

Rong Sun et al.

Summary: The authors have developed a bacteria-based drug delivery system for the treatment of glioblastoma. This system bypasses the blood-brain barrier and uses photothermal therapy and immune responses to destroy bacteria-infected glioblastoma cells and prolong the survival of mice. The residual bacteria can also be effectively eliminated from the body.

NATURE COMMUNICATIONS (2022)

Article Biotechnology & Applied Microbiology

AGuIX nanoparticles enhance ionizing radiation-induced ferroptosis on tumor cells by targeting the NRF2-GPX4 signaling pathway

Hao Sun et al.

Summary: This study demonstrated the effectiveness of AGuIX nanoparticles in radio-sensitization of triple-negative breast cancer. It increased DNA damage level by compromising the homologous recombination repair pathway and may regulate the anti-ferroptosis system by inhibiting the NRF2-GSH-GPX4 signaling pathway.

JOURNAL OF NANOBIOTECHNOLOGY (2022)

Article Multidisciplinary Sciences

NIR-II fluorescence visualization of ultrasound-induced blood-brain barrier opening for enhanced photothermal therapy against glioblastoma using indocyanine green microbubbles

Simin Liang et al.

Summary: In this study, microbubbles (MBs) doped with indocyanine green (ICG) were used to visualize the blood-brain barrier (BBB) opening induced by focused ultrasound (FUS) and enhance photothermal therapy (PTT) against glioblastoma (GBM). MBs-ICG exhibited bright fluorescence in the second near-infrared window (NIR-II), ultrasound contrast, and ultrasound-induced size transformation properties. By combining MBs-ICG with FUS, the BBB opening process could be visualized in real time with a high signal-to-background ratio.

SCIENCE BULLETIN (2022)

Article Chemistry, Multidisciplinary

Controlling Disassembly of Paramagnetic Prodrug and Photosensitizer Nanoassemblies for On-Demand Orthotopic Glioma Theranostics

Ruibing An et al.

Summary: This study presents a glioma targeting and redox activatable theranostic nanoprobe for on-demand synergistic chemotherapy/photodynamic therapy (Chemo-PDT) of orthotopic gliomas. The nanoprobe disassembles and releases small molecules upon reduction by endogenous glutathione, allowing for synergistic Chemo-PDT. Additionally, the nanoprobe is capable of noninvasive detection and monitoring of orthotopic brain tumor growth. This research highlights the potential of targeted and activatable nanoagents for combinational cancer theranostics.

ACS NANO (2022)

Review Engineering, Biomedical

Biopolymer Nanoparticles for Nose-to-Brain Drug Delivery: A New Promising Approach for the Treatment of Neurological Diseases

Nicolo Montegiove et al.

Summary: This article discusses the use of polymer nanoparticles to deliver drugs to the brain through the nose-to-brain route. This method is currently being widely used for the treatment of neurological diseases such as glioblastoma and neurodegenerative diseases.

JOURNAL OF FUNCTIONAL BIOMATERIALS (2022)

Article Biochemistry & Molecular Biology

Exploration and functionalization of M1-macrophage extracellular vesicles for effective accumulation in glioblastoma and strong synergistic therapeutic effects

Xiaojun Wang et al.

Summary: The researchers successfully developed M1-like macrophage-derived extracellular vesicles (M1EVs) for the treatment of glioblastoma multiforme (GBM). These M1EVs achieved synergistic immunomodulation, chemiexcited photodynamic therapy (CDT), and hypoxia-activated chemotherapy in GBM, leading to a potent therapeutic effect. The results demonstrated the excellent efficacy of CCA-M1EVs against GBM in cell-derived and patient-derived xenograft models.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Article Chemistry, Physical

Silicon-based nanoprobes cross the blood-brain barrier for photothermal therapy of glioblastoma

Rong Sun et al.

Summary: The newly developed SiNPs-based nanoprobes can effectively bypass the blood-brain barrier and accumulate in GBM tissues. Compared with free ICG, G-ICG-SiNPs exhibit stronger stability and longer blood circulation time, indicating superior photothermal effects.

NANO RESEARCH (2022)

Article Materials Science, Multidisciplinary

Iron oxide nanoparticle-mediated radiation delivery for glioblastoma treatment

Peter A. Chiarelli et al.

Summary: This study introduces a tumor-targeted iron oxide nanoparticle that enhances the effectiveness of conventional radiotherapy for GBM, leading to significant improvements in tumor growth and prognosis.

MATERIALS TODAY (2022)

Review Neurosciences

Drug Delivery Nanosystems in Glioblastoma Multiforme Treatment: Current State of the Art

Leonardo Delello Di Filippo et al.

Summary: GBM, the most common malignant CNS cancer, is a fatal disease with limited treatment options. Drug encapsulation in nanosystems shows promise in reducing systemic toxicity and improving drug bioavailability. The development of more effective drug delivery systems is crucial for the future of GBM treatment.

CURRENT NEUROPHARMACOLOGY (2021)

Review Clinical Neurology

Applications of focused ultrasound in the brain: from thermoablation to drug delivery

Ying Meng et al.

Summary: Focused ultrasound (FUS) is a disruptive medical technology that can precisely intervene in key circuits of brain disorders, with various forms of actions such as blood-brain barrier opening and neuromodulation. In recent years, there has been a significant expansion of FUS applications in humans, leading to increased academic and public interest in the technology.

NATURE REVIEWS NEUROLOGY (2021)

Review Pharmacology & Pharmacy

Understanding Drug Delivery to the Brain Using Liposome-Based Strategies: Studies that Provide Mechanistic Insights Are Essential

Firda Juhairiyah et al.

Summary: The review summarizes the challenges of brain drug delivery due to the blood-brain barrier and the current strategies using liposome-based drug delivery. Findings suggest that liposomal formulations may provide interesting changes in BBB transport, but further mechanistic studies are needed to understand their application in humans.

AAPS JOURNAL (2021)

Article Chemistry, Multidisciplinary

A Microfluidics-Based Scalable Approach to Generate Extracellular Vesicles with Enhanced Therapeutic MicroRNA Loading for Intranasal Delivery to Mouse Glioblastomas

Kai Wang et al.

Summary: A scalable microfluidic platform was developed to load therapeutic miRNAs and drugs into EVs while controlling their size, leading to improved treatment outcomes in orthotopic GBM mouse models. The engineered mpEVs demonstrated efficient delivery of miRNAs and drugs to GBM cells, resulting in tumor regression and increased survival rates in mice, showing potential for clinical translation in GBM therapy.

ACS NANO (2021)

Review Pharmacology & Pharmacy

Evolution of blood-brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies

Liang Han et al.

Summary: This review focuses on nanoscale brain-targeting drug delivery strategies designed based on blood-brain barrier (BBB) alterations and their applications in various brain diseases. However, advances on optimization of small molecules for BBB crossing and non-systemic administration routes such as intranasal treatment are not included in this review.

ACTA PHARMACEUTICA SINICA B (2021)

Article Engineering, Biomedical

Tumor cell-targeting radiotherapy in the treatment of glioblastoma multiforme using linear accelerators

Chih-Sheng Chiang et al.

Summary: TSER is a strategy for achieving precision cell-targeted radiotherapy using common linear accelerators, involving a combination of GoldenDisk, 5-ALA, low-intensity ultrasound, and low-dose radiation therapy. It exhibited synergized radiosensitization effects and showed enhanced therapeutic effect and survival in the treatment of an orthotropic GBM model with only 20% of the radiation dose.

ACTA BIOMATERIALIA (2021)

Article Oncology

MR-guided focused ultrasound liquid biopsy enriches circulating biomarkers in patients with brain tumors

Ying Meng et al.

Summary: This study demonstrates that MRgFUS has the potential to enrich circulating brain-derived biomarkers, showing promising applications for liquid biopsy in the brain.

NEURO-ONCOLOGY (2021)

Review Chemistry, Multidisciplinary

Development of Polymeric Nanoparticles for Blood-Brain Barrier Transfer-Strategies and Challenges

Weisen Zhang et al.

Summary: Polymeric nanoparticles have shown great potential in overcoming the blood-brain barrier for effective drug delivery, with their unique properties offering high tunability and ease of synthesis. Careful analysis of their performance in transporting drugs across the blood-brain barrier is essential for successful drug delivery to the central nervous system.

ADVANCED SCIENCE (2021)

Article Chemistry, Multidisciplinary

Interfacially Engineered ZnxMn1-xS@Polydopamine Hollow Nanospheres for Glutathione Depleting Photothermally Enhanced Chemodynamic Therapy

Juan Ruan et al.

Summary: The Fenton-like reactions driven by manganese-based nanostructures can be tuned by a controllable release of Mn ions, leading to specific toxicity to cancer cells. The ZnxMn1-xS@PDA composites show potential for synergistic chemodynamic and photothermal therapies for cancer treatment.

ACS NANO (2021)

Article Chemistry, Multidisciplinary

Cation-Free siRNA Micelles as Effective Drug Delivery Platform and Potent RNAi Nanomedicines for Glioblastoma Therapy

Tong Jiang et al.

Summary: The novel cation-free siRNA micelles show enhanced blood circulation time, superior cell uptake, potent BBB penetration, and no charge-associated toxicity, resulting in outstanding growth inhibition of orthotopic U87MG xenografts and remarkably improved survival benefits for GBM treatment. Additionally, these siRNA micelles display effective drug loading ability, and when combined with temozolomide, they achieve effective synergistic therapy by targeting key drug-resistant pathways. The siRNA micelle nanoparticle serves as a robust and versatile drug co-delivery platform for effective GBM treatment.

ADVANCED MATERIALS (2021)

Review Materials Science, Biomaterials

Unravelling the potential of graphene in glioblastoma therapy

Cher Ying Foo et al.

Summary: Glioblastoma multiforme is a highly malignant type of tumor with poor prognosis. The use of graphene, a nanomaterial with unique characteristics, has shown promise in overcoming challenges in GBM treatment by providing a versatile platform for multiple therapeutic modalities. This review discusses the current applications of graphene-based materials in GBM diagnosis and therapy, highlighting potential pathways towards improving the safety and efficacy of graphene-based therapeutics.

MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2021)

Article Multidisciplinary Sciences

Heterogeneity of meningeal B cells reveals a lymphopoietic niche at the CNS borders

Simone Brioschi et al.

Summary: The meninges contain adaptive immune cells called B cells that are thought to originate locally from the calvaria, providing a constant supply of CNS-educated B cells. Additionally, a subset of antigen-experienced B cells in the meninges of aging mice are found to be blood-borne, suggesting a potential mechanism for maintaining immune privilege within the CNS.

SCIENCE (2021)

Article Biotechnology & Applied Microbiology

Multi-responsive nanofibers composite gel for local drug delivery to inhibit recurrence of glioma after operation

Yufu Zhu et al.

Summary: The study synthesized reactive oxygen species (ROS)-triggered poly(propylene sulfide)60 (PPS60) mixed with matrix metalloproteinases (MMPs)-responsive triglycerol monostearate (T) lipids and TMZ to generate hydrogels with MMPs- and ROS-responsiveness. The hydrogel effectively inhibited the growth of recurrent glioma after surgery by achieving the sustained release of TMZ in the surgical cavity.

JOURNAL OF NANOBIOTECHNOLOGY (2021)

Article Biotechnology & Applied Microbiology

RVG-functionalized reduction sensitive micelles for the effective accumulation of doxorubicin in brain

Jiangkang Xu et al.

Summary: The study demonstrated that RVG-modified nanomicelles can enhance drug accumulation in the brain and inhibit tumor growth effectively, leading to significantly improved survival rate with minimal systemic toxicity.

JOURNAL OF NANOBIOTECHNOLOGY (2021)

Article Biotechnology & Applied Microbiology

Image-guided selection of Gd@C-dots as sensitizers to improve radiotherapy of non-small cell lung cancer

Xiaofen Ma et al.

Summary: In this study, two Gd@C-dots formulations were developed with carboxylic acid (CA-Gd@C-dots) or amino group (pPD-Gd@C-dots) on the carbon shell. PET imaging showed significantly improved tumor retention of Cu-64-labeled pPD-Gd@C-dots compared to CA-Gd@C-dots, indicating the potential of pPD-Gd@C-dots as an effective radiosensitizer for cancer therapy.

JOURNAL OF NANOBIOTECHNOLOGY (2021)

Article Materials Science, Biomaterials

Novel Treatment for Glioblastoma Delivered by a Radiation Responsive and Radiopaque Hydrogel

Mathilde Bouche et al.

Summary: A injectable hydrogel loaded with quisinostat drug and gold nanoparticles was successfully used to inhibit tumor growth in glioblastoma, showing high anticancer activity in vitro. By combining radiotherapy and radiation-triggered drug delivery, the hydrogel demonstrated a total response rate of 67% in a mice model. The use of gold nanoparticles allowed for precise image-guided radiation delivery and monitoring of hydrogel degradation using computed tomography.

ACS BIOMATERIALS SCIENCE & ENGINEERING (2021)

Article Nanoscience & Nanotechnology

Angiopep2-Conjugated Star-Shaped Polyprodrug Amphiphiles for Simultaneous Glioma-Targeting Therapy and MR Imaging

Xiao Wang et al.

ACS APPLIED MATERIALS & INTERFACES (2020)

Review Pharmacology & Pharmacy

Physical triggering strategies for drug delivery

Tao Sun et al.

ADVANCED DRUG DELIVERY REVIEWS (2020)

Article Chemistry, Multidisciplinary

Rabies Virus-Inspired Metal-Organic Frameworks (MOFs) for Targeted Imaging and Chemotherapy of Glioma

Chaoqiang Qiao et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)

Review Oncology

Management of glioblastoma: State of the art and future directions

Aaron C. Tan et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Review Pharmacology & Pharmacy

Gold Nanoparticles in Glioma Theranostics

Mohammad Norouzi

PHARMACOLOGICAL RESEARCH (2020)

Article Chemistry, Multidisciplinary

Intratumoral injection of hydrogel-embedded nanoparticles enhances retention in glioblastoma

Giulia Brachi et al.

NANOSCALE (2020)

Review Oncology

Central Nervous System Cancers Version 3.2020

Louis Burt Nabors et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)

Article Chemistry, Multidisciplinary

Ligand-Modified Cell Membrane Enables the Targeted Delivery of Drug Nanocrystals to Glioma

Zhilan Chai et al.

ACS NANO (2019)

Article Multidisciplinary Sciences

A biosensor capable of identifying low quantities of breast cancer cells by electrical impedance spectroscopy

L. F. E. Huerta-Nunez et al.

SCIENTIFIC REPORTS (2019)

Article Chemistry, Multidisciplinary

Tumor-Derived Extracellular Vesicles Breach the Intact Blood-Brain Barrier via Transcytosis

Golnaz Morad et al.

ACS NANO (2019)

Review Biochemistry & Molecular Biology

Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials

Franciele Aline Bruinsmann et al.

MOLECULES (2019)

Review Biotechnology & Applied Microbiology

microRNAs: Potential glioblastoma radiosensitizer by targeting radiation-related molecular pathways

Mohammad-Taghi Bahreyni-Toossi et al.

MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2019)

Article Multidisciplinary Sciences

Brain-targeted drug delivery by manipulating protein corona functions

Zui Zhang et al.

NATURE COMMUNICATIONS (2019)

Review Engineering, Biomedical

Nanomaterial-based blood-brain-barrier (BBB) crossing strategies

Jinbing Xie et al.

BIOMATERIALS (2019)

Article Chemistry, Multidisciplinary

Radiation-Induced Targeted Nanoparticle-Based Gene Delivery for Brain Tumor Therapy

Gulsah Erel-Akbaba et al.

ACS NANO (2019)

Article Chemistry, Multidisciplinary

Systemic Delivery of Monoclonal Antibodies to the Central Nervous System for Brain Tumor Therapy

Lei Han et al.

ADVANCED MATERIALS (2019)

Review Medicine, Research & Experimental

Mechanism of intranasal drug delivery directly to the brain

Tyler P. Crowe et al.

LIFE SCIENCES (2018)

Article Biotechnology & Applied Microbiology

Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma

Christine E. Brown et al.

MOLECULAR THERAPY (2018)

Review Oncology

Current state of immunotherapy for glioblastoma

Michael Lim et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Article Multidisciplinary Sciences

Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy

Kaiyuan Ni et al.

NATURE COMMUNICATIONS (2018)

Article Chemistry, Multidisciplinary

Liposomal temozolomide drug delivery using convection enhanced delivery

Mirjam M. Nordling-David et al.

JOURNAL OF CONTROLLED RELEASE (2017)

Article Chemistry, Multidisciplinary

pH-Sensitive Dissociable Nanoscale Coordination Polymers with Drug Loading for Synergistically Enhanced Chemoradiotherapy

Jingjing Liu et al.

ADVANCED FUNCTIONAL MATERIALS (2017)

Review Chemistry, Multidisciplinary

Continuous Hydrothermal Synthesis of Inorganic Nanoparticles: Applications and Future Directions

Jawwad A. Darr et al.

CHEMICAL REVIEWS (2017)

Article Oncology

The Microenvironmental Landscape of Brain Tumors

Daniela F. Quail et al.

CANCER CELL (2017)

Review Pharmacology & Pharmacy

Radiation effects on the tumor microenvironment: Implications for nanomedicine delivery

Shawn Stapleton et al.

ADVANCED DRUG DELIVERY REVIEWS (2017)

Article Nanoscience & Nanotechnology

Tailoring Particle Size of Mesoporous Silica Nanosystem To Antagonize Glioblastoma and Overcome Blood-Brain Barrier

Jianbin Mo et al.

ACS APPLIED MATERIALS & INTERFACES (2016)

Article Environmental Sciences

Toxicity of different forms of graphene in a chicken embryo model

Maciej Szmidt et al.

ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2016)

Article Biochemistry & Molecular Biology

Effects of GSM modulated radio-frequency electromagnetic radiation on permeability of blood-brain barrier in male & female rats

Bahriye Sirav et al.

JOURNAL OF CHEMICAL NEUROANATOMY (2016)

Review Pharmacology & Pharmacy

Progress and perspectives on targeting nanoparticles for brain drug delivery

Huile Gao

ACTA PHARMACEUTICA SINICA B (2016)

Review Medicine, Research & Experimental

Junctional proteins of the blood-brain barrier: New insights into function and dysfunction

Svetlana M. Stamatovic et al.

TISSUE BARRIERS (2016)

Article Medicine, Research & Experimental

Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype

Konrad Gabrusiewicz et al.

JCI INSIGHT (2016)

Review Pharmacology & Pharmacy

Overcoming the blood-brain tumor barrier for effective glioblastoma treatment

O. van Tellingen et al.

DRUG RESISTANCE UPDATES (2015)

Review Cell Biology

Brain barriers: Crosstalk between complex tight junctions and adherens junctions

Silvia Tietz et al.

JOURNAL OF CELL BIOLOGY (2015)

Article Biotechnology & Applied Microbiology

Gene delivery by a cationic and thermosensitive nanogel promoted established tumor growth inhibition

Peng Cao et al.

NANOMEDICINE (2015)

Article Nanoscience & Nanotechnology

VEGF121-Conjugated Mesoporous Silica Nanoparticle: A Tumor Targeted Drug Delivery System

Shreya Goel et al.

ACS APPLIED MATERIALS & INTERFACES (2014)

Article Chemistry, Multidisciplinary

DNA-Hybrid-Gated Multifunctional Mesoporous Silica Nanocarriers for Dual-Targeted and MicroRNA-Responsive Controlled Drug Delivery**

Penghui Zhang et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)

Article Engineering, Biomedical

A systems toxicology approach to the surface functionality control of graphene-cell interactions

Nivedita Chatterjee et al.

BIOMATERIALS (2014)

Article Biochemical Research Methods

Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB)

Ross Booth et al.

LAB ON A CHIP (2012)

Review Pharmacology & Pharmacy

Cell-mediated drug delivery

Elena V. Batrakova et al.

EXPERT OPINION ON DRUG DELIVERY (2011)

Review Pharmacology & Pharmacy

Tight junctions of the blood-brain barrier: Development, composition and regulation

H Wolburg et al.

VASCULAR PHARMACOLOGY (2002)